Insiders · QDEL

Matthew Strobeck

Director at QuidelOrtho Corp (QDEL)

Matthew Strobeck has filed 37 insider reports with the SEC since February 2021, as director at QuidelOrtho Corp (QDEL), director at Biodesix Inc (BDSX) and director at Accelerate Diagnostics, Inc (AXDX). In the last 12 months Matthew Strobeck bought $240K of stock on the open market. The latest filing, on June 2, 2026, reports grant or award and exercise or conversion of a derivative at QuidelOrtho Corp (QDEL).

Filings
37
Companies
3
Bought on market
$6.01M
Sold on market
None

Companies where Matthew Strobeck is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
QuidelOrtho Corp logo
QDEL
QuidelOrtho Corp
Director34,604$240K$23.96$8.32-65%Jun 2, 2026
Biodesix Inc logo
BDSX
Biodesix Inc
Director2,542,928$5.77M$1.45$7.56+421%Jan 6, 2026
Accelerate Diagnostics, Inc logo
AXDX
Accelerate Diagnostics, Inc
Director202,556Jan 25, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Matthew Strobeck.

Compare Matthew Strobeck with

Other insiders at the same companies

Questions about Matthew Strobeck

What is Matthew Strobeck's role at QuidelOrtho Corp?
Matthew Strobeck reports to the SEC as director at QuidelOrtho Corp (QDEL), according to the latest filing on June 2, 2026. Matthew Strobeck has also filed as director at Biodesix Inc (BDSX) and director at Accelerate Diagnostics, Inc (AXDX).
How many shares does Matthew Strobeck own?
After the latest filing that states it, Matthew Strobeck directly owned 34,604 shares of QuidelOrtho Corp (QDEL), 2,542,928 shares of Biodesix Inc (BDSX) and 202,556 shares of Accelerate Diagnostics, Inc (AXDX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Matthew Strobeck bought or sold stock recently?
The most recent open-market purchase was on February 13, 2026: bought 10,000 shares of QuidelOrtho Corp (QDEL) for $240K at an average of $23.96.
How do I get alerts when Matthew Strobeck files?
Follow Matthew Strobeck on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Matthew Strobeck (SEC CIK 0001377832). Totals count each trade once, skipping amendments whose original is on file, from Feb 24, 2021 on. View on SEC EDGAR · Get this as JSON